Adarza Aims to Launch Biomarker Detection Platform Next Year; Adds Former Roche CEO to Board | GenomeWeb

By Molika Ashford

Rochester, NY-based diagnostics firm Adarza Biosystems announced last week two additions to its board of directors, including Heiner Dreismann, former CEO of Roche Molecular Systems.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.